Consistent with the transcriptomic datasets, Acly-KO mice had increases in the number of B cells at the tumour periphery, with non-significant increases in T cells or other immune cell populations (Fig. 5b–d); findings that were confirmed using immunohistochemical staining of CD19+ B cells (Fig. 5e). The gene discussed is ACLY; the disease is neoplasm.